Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Washington University School of Medicine
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Chicago
Grupo Espanol de Tumores Neuroendocrinos
Jonsson Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Minia University
Università Cattolica di Milano
M.D. Anderson Cancer Center
Fudan University
Fudan University
Fudan University
Ankara University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
South Egypt Cancer Institute
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Fujian Medical University